145 results on '"leiomyosarcoma"'
Search Results
2. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
3. Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
4. Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma (ISG-ARTICLE)
5. Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (ALCI2)
6. Letrozole in Uterine Leiomyosarcoma
7. Circulating ' Cancer Cells / Macrophage ' HYbrid Cells in Patients With Sarcoma, Part 2 (SAMHY2)
8. Study of Lurbinectedin in Combination with Doxorubicin Versus Doxorubicin Alone As First-line Treatment in Participants with Metastatic Leiomyosarcoma (SaLuDo)
9. A Study to Evaluate Tabelecleucel in Participants with Epstein-barr Virus-associated Diseases
10. A Study of Nivolumab in Selected Uterine Cancer Patients
11. Metastatic Leiomyosarcoma Biomarker Protocol
12. A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
13. A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
14. Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour (L-UteCIN)
15. Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
16. Nanatinostat Plus Valganciclovir in Patients With Advanced EBV+ Solid Tumors, and in Combination With Pembrolizumab in EBV+ RM-NPC
17. Lurbinectedin + Doxorubicin In Leiomyosarcoma
18. Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
19. A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma (TTI-621-03)
20. Pazopanib Vs. Pazopanib Plus Gemcitabine (PazoDoble)
21. NM32-2668 in Adult Patients with Selected Advanced Solid Tumors
22. Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
23. Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS
24. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2)
25. XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
26. Agnostic Therapy in Rare Solid Tumors (ANTARES)
27. Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
28. Treatment with Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients with Leiomyosarcoma (DiTuSarc)
29. AOH1996 for the Treatment of Refractory Solid Tumors
30. Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma (LEADER)
31. Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
32. A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
33. Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA)
34. Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
35. CytoreductiveSurgery & HIPEC W/Gemcitabine+Chemotherapy W/Dacarbazine in Uterine Leiomyosarcoma
36. A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
37. A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers (FFCD-2205)
38. A Phase II Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
39. Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
40. Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
41. The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions (MYSTR)
42. Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
43. Localized Leiomyosarcoma Biomarker Protocol
44. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) (SUNRISELMS)
45. FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study (FUCHSia)
46. Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
47. Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
48. A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
49. A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
50. Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors (DAPPER)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.